Companies / Nephrogen
Nephrogen
United States
Nephrogen is building curative genetic medicines for kidney and pancreatic diseases using an AI screening platform to solve gene delivery for serious diseases.
Nephrogen, based in United States, has 4 investors on file, among them StartX, Techstars and Y Combinator. Its latest round on record is Seed, 15 Aug 2025. Its site was last checked 12 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Accelerator | |
| Portfolio page | Accelerator | |
| Portfolio page | Accelerator | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Nephrogen and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when StartX adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/nephrogenbiotech.com/investors
# also
GET /v1/companies/nephrogenbiotech.com
GET /v1/companies/nephrogenbiotech.com/news